Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.
| Image |  |
|---|---|
| Description | scientific article published on 16 March 2015 |
| Author/s |
author: Gerd Mikus Christoph Springfeld Nicolas Hohmann Jürgen Weitz Thomas Schmidt Walter E Haefeli |
| Publication date | March 16, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |